CJC-1295 without DAC, also known as Modified GRF 1-29, is a synthetic peptide that stimulates the release of growth hormone by acting on the growth hormone-releasing hormone (GHRH) receptors in the brain. Unlike its counterpart with DAC, this version does not include the Drug Affinity Complex, resulting in a shorter half-life and a more pulsatile release of growth hormone.

The primary function of CJC-1295 without DAC is to increase the levels of growth hormone and IGF-1 (Insulin-like Growth Factor 1) in the body. This leads to several benefits, including:

• Increased Muscle Mass: By promoting protein synthesis and muscle growth, it helps in building lean body mass.

• Improved Recovery: It enhances the body's ability to recover from injuries and intense physical activities.

• Fat Loss: The peptide aids in reducing body fat by improving metabolism and increasing the breakdown of fat cells.

• Enhanced Immune Function: It supports the immune system, making the body more resilient to infections and diseases.

• Anti-Aging Effects: By boosting growth hormone levels, it helps reduce the signs of aging and improves overall vitality.

CJC-1295 without DAC is often used in research and performance enhancement due to its ability to provide specific and targeted effects without the prolonged action seen with the DAC version

Check out Jay Campbell's website, which is an excellent source for peptide research.